Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on August 31st, 2016 by Dr Andrew A. Parsons in Pharma R&D
According to Jon Kolko (HBR 2015), the age of “design thinking” is here. Several high tech companies appear to be taking simple design principals in moving from selling products to providing services for their users or clients. Continue reading “Is it time for Design Thinking to drive R&D?” »
Posted on August 29th, 2016 by Betsy Davis in Pharma R&D
In a new feature in The Atlantic, author Jessa Gamble makes the case that Modern Medicine Is Too Reliant on Short-Term Studies, too often preferring the instant gratification that comes from a short study, only to find those results soon challenged by yet another short-term study.
Posted on August 26th, 2016 by Dr. Makarand Jawadekar, Ph.D in Chemistry
In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.
Posted on August 24th, 2016 by Patrick C. May, PH.D. in Pharma R&D
In a previous blog, I provided a few thoughts on tau-related drug discovery news coming out of the recent Alzheimer’s Association International Conference (AAIC16) in Toronto, Canada. In this post, I will highlight some of the research from the conference on gamma and beta-secretase, Continue reading “Review of Alzheimer’s Association International Conference (AAIC16) Part 2: Focus on Secretases” »